FDA Adverse Event Injury Summary report: N

ACRYSOF

MDR report key: 3010257 · Received March 12, 2013

Report

Report Number
1119421-2013-00257
Event Type
Injury
Date Received
March 12, 2013
Date of Event
January 1, 2013
Report Date
February 11, 2013
Manufacturer
ALCON RESEARCH, LTD/HUNTINGTON
Product Code
HQL
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. RESULTS FROM THE PRODUCT HISTORY RECORD REVIEW INDICATED THE PRODUCT MET RELEASE CRITERIA. THE PRODUCT INVESTIGATION COULD NOT IDENTIFY A ROOT CAUSE. THERE WERE NO OTHER COMPLAINTS REPORTED FOR THIS LOT. (B)(4).

Description of Event or Problem · 1

A CONSUMER REPORTED THAT FOLLOWING BILATERAL INTRAOCULAR LENS IMPLANT SURGERIES, HER DISTANCE VISION WAS WORSE THAN PRIOR TO SURGERY. SHE ALSO REPORTED SEEING HALOS AND "HEADLIGHTS ARE BLINDING". SHE IS NOT COMFORTABLE DRIVING AT NIGHT. SHE REPORTED THAT SHE CANNOT READ STREET SIGNS OR OVERHEAD SIGNS AT THE GROCERY STORE. HER NEAR VISION IS GOOD, BUT DISTANCE VISION IS BLURRED. THE CONSUMER SPOKE TO HER SURGEON AND HE TOLD HER "IT WAS TOO EARLY AND SHE SHOULD GIVE IT MORE TIME". SHE ALSO REPORTED THAT SHE HAS HAD MULTIPLE CONDUCTIVE KERATOPLASTY (CK) PROCEDURES DONE ON HER LEFT EYE IN THE PAST, PRIOR TO IMPLANT SURGERY. ADD'L INFO WAS RECEIVED FROM THE SURGEON, WHO INDICATED THE PT DID NOT USE POST OPERATIVE MEDICATIONS AS PRESCRIBED. IN HIS OPINION, THE IOL DID NOT CAUSE THE EVENT. DURING A F/U WITH THE SURGEON, HE INDICATED THAT HE EXPLAINED TO THE PT THAT THE PREVIOUS CK PROCEDURES, COULD "THROW OFF" THE IOL MEASUREMENTS TAKEN PRIOR TO IMPLANT SURGERY. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS REPORT IS FOR THE LEFT EYE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
104319 ACRYSOF INTRAOCULAR LENS HQL ALCON RESEARCH, LTD/HUNTINGTON SN60WF 12162904

Patients

Seq Age Sex Outcome Treatment
1 68 YR Other PROVISC| VISCOAT